Table 4 Laboratory parameters of hypertensive and non- hypertensive COVID-19 patients without other comorbidities

5.23 (3.90–7.67)

3.25 (2.34–9.51)

7.36 (4.86–9.73)

0.002

3.79 (2.59–6.18)

2.52 (1.62–8.63)

7.92 (3.43–8.86)

0.003

0.86 (0.59–1.19)

0.54 (0.48–0.62)

0.65 (0.40–0.85)

0.624

4.63 (2.48–8.44)

5.15 (3.03–13.81)

14.96 (3.6–20.23)

0.042

96.0 (91.3–98.0)

95.4 (91.5–98.1)

94.8 (82.0–96.7)

0.001

11.15 (8.48–15.10)

10.55 (8.78–13.00)

10.60 (9.75–13.40)

0.375

27.4 (17.9–48.0)

20.0 (9.50–26.0)

46.5 (22.3–204.8)

0.001

32.0 (23.0–47.3)

36.5 (32.3–40.8)

33.5 (25.8–94.8)

0.060

34.2 (30.5–38.1)

28.3 (27.2–32.0)

30.4 (29.0–32.3)

0.008

30.5 (26.1–34.6)

29.4 (25.0–32.2)

29.8 (26.6–32.9)

0.129

286 (207–409)

302 (250–407)

316 (245–412)

0.038

68.00 (55.50–81.35)

76.35 (56.43–87.43)

64.50 (54.18–110.15)

0.090

46.2 (25.3–62.5)

42.0 (19.3–58.8)

49.0 (25.0–77.8)

0.160

13.2 (2.9–61.7)

44.4 (39.8–146.1)

31.4 (16.9–96.0)

0.011

790.52 (401.97–1324.91)

1082.60 (617.30–1339.50)

762.72 (533.98–1178.14)

0.288

9.36 (6.52–13.80)

9.10 (5.44–34.27)

9.62 (6.51–13.47)

0.194

62.9 (26.6–115.8)

73.0 (32.4–253.5)

73.2 (30.0–127.7)

0.877

0.67 (0.42–1.79)

0.74 (0.48–2.06)

1.09 (0.56–3.48)

0.013

3.60 (2.86–4.80)

4.35 (3.53–5.55)

4.50 (3.83–6.25)

0.036

11.3 (10.6–12.2)

11.5 (10.1–12.5)

11.5 (10.0–12.5)

0.127

28.2 (25.0–32.5)

30.8 (26.5–33.6)

22.3 (19.3–32.2)

0.004